Page last updated: 2024-08-21

adamantane and Gastric Diseases

adamantane has been researched along with Gastric Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arab, HH; Ashour, AM; Gad, AM; Kabel, AM; Mahmoud, AM	1

Other Studies

1 other study(ies) available for adamantane and Gastric Diseases

Article	Year
Activation of AMPK/mTOR-driven autophagy and inhibition of NLRP3 inflammasome by saxagliptin ameliorate ethanol-induced gastric mucosal damage. Life sciences, 2021, Sep-01, Volume: 280 Topics: Adamantane; AMP-Activated Protein Kinase Kinases; Animals; Autophagy; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Ethanol; Inflammasomes; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinases; Rats, Wistar; Signal Transduction; Stomach Diseases; TOR Serine-Threonine Kinases	2021

Article

Year

Activation of AMPK/mTOR-driven autophagy and inhibition of NLRP3 inflammasome by saxagliptin ameliorate ethanol-induced gastric mucosal damage.

Life sciences, 2021, Sep-01, Volume: 280

Topics: Adamantane; AMP-Activated Protein Kinase Kinases; Animals; Autophagy; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Ethanol; Inflammasomes; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinases; Rats, Wistar; Signal Transduction; Stomach Diseases; TOR Serine-Threonine Kinases

2021